On 8 December 2021, the Clinigen Group Plc Board and the Triley Bidco Limited Board announced that, they had reached agreement on the terms of a recommended all-cash acquisition of Clinigen by Triley Bidco, a newly incorporated company indirectly owned by the Triton Funds pursuant to which Triley Bidco will acquire the entire issued and to be issued ordinary share capital of the Company to be effected by means of a Court sanctioned scheme of arrangement under Part 26 of the Companies Act. Further, the circular in relation to the Scheme was published on 20 December 2021 and the Court Meeting and General Meeting have been convened for 18 January 2022.